Analyst: Buy AstraZeneca On The Turnaround Story
February 22, 2017 at 07:29 AM EST
Following AstraZeneca plc (ADR) (NYSE: AZN)’s strong start to 2017, including a positive data report for breast cancer treatment ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.